328 related articles for article (PubMed ID: 17573020)
1. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
Asfar S; Safar HA
J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia in patients with arterial occlusive disease.
Aksoy M; Basar Y; Salmayenli N; Ayalp K; Genc FA; Dilege S; Kayabali M; Baktiroglu S; Kurtoglu M
Surg Today; 2006; 36(4):327-31. PubMed ID: 16554989
[TBL] [Abstract][Full Text] [Related]
4. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
5. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
Lijfering WM; Veeger NJ; Brouwer JL; van de Poel MH; van der Meer J
J Thromb Haemost; 2007 Mar; 5(3):614-6. PubMed ID: 17181828
[No Abstract] [Full Text] [Related]
6. Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients.
Omar S; Ghorbel IB; Feki H; Souissi M; Feki M; Houman H; Kaabachi N
Clin Biochem; 2007 Jan; 40(1-2):41-5. PubMed ID: 17020757
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.
Vuckovic BA; Cabarkapa VS; Ilic TA; Salatic IR; Lozanov-Crvenkovic ZS; Mitic GP
Croat Med J; 2013 Oct; 54(5):480-8. PubMed ID: 24170727
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia prevalence among patients with venous thromboembolism.
Köktürk N; Kanbay A; Aydoğdu M; Özyılmaz E; Bukan N; Ekim N
Clin Appl Thromb Hemost; 2011 Oct; 17(5):487-93. PubMed ID: 20699251
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and retinal vascular occlusive disease.
Abu El-Asrar AM; Abdel Gader AG; Al-Amro SA; Al-Attas OS
Eur J Ophthalmol; 2002; 12(6):495-500. PubMed ID: 12510718
[TBL] [Abstract][Full Text] [Related]
10. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
15. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine cutoff values for venous thrombosis.
Castañon MM; Lauricella AM; Kordich L; Quintana I
Clin Chem Lab Med; 2007; 45(2):232-6. PubMed ID: 17311514
[TBL] [Abstract][Full Text] [Related]
17. Oral challenge with a methionine load in patients with inflammatory bowel disease: a better test to identify hyperhomocysteinemia.
Zepeda-Gómez S; Montano-Loza A; Zapata-Colindres JC; Vargas-Vorackova F; Majluf-Cruz A; Uscanga L
Inflamm Bowel Dis; 2008 Mar; 14(3):383-8. PubMed ID: 17924554
[TBL] [Abstract][Full Text] [Related]
18. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine in occlusive vascular disease: a risk marker or risk factor.
Bhargava S; Ali A; Manocha A; Kankra M; Das S; Srivastava LM
Indian J Biochem Biophys; 2012 Dec; 49(6):414-20. PubMed ID: 23350275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
